Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of bio pharmaceutical services. The company's technology is a potent TLR7 agonist which can be used as an immunomodulating agent or as a vaccine platform.
You’re viewing a free company profile from the PitchBook Platform. To explore Folia Biotech’s full profile, request a free trial.
This information is reserved for PitchBook Platform users. To explore Folia Biotech‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.